+23.4%
REGN vs GSK
+47.2%
-23.9%
-59.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.5% | 0.0% | -1.5% | -1.5% |
| 7D | -5.6% | -3.5% | -2.1% | -4.3% |
| 30D | -2.0% | -3.4% | +1.5% | -0.6% |
| 3M | +28.0% | -8.1% | +36.1% | +31.9% |
| 6M | +1.2% | -11.1% | +12.3% | +5.4% |
| YTD | +1.6% | +0.7% | +0.9% | +1.2% |
| 1Y | +38.2% | +20.1% | +18.1% | +29.1% |
| 3Y | -5.4% | +46.1% | -51.5% | -19.0% |
| All | +23.4% | +47.2% | -23.9% | -2.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling